BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30235485)

  • 1. Docking of Meprin α to Heparan Sulphate Protects the Endothelium from Inflammatory Cell Extravasation.
    Biasin V; Wygrecka M; Bärnthaler T; Jandl K; Jain PP; Bálint Z; Kovacs G; Leitinger G; Kolb-Lenz D; Kornmueller K; Peters F; Sinn K; Klepetko W; Heinemann A; Olschewski A; Becker-Pauly C; Kwapiszewska G
    Thromb Haemost; 2018 Oct; 118(10):1790-1802. PubMed ID: 30235485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meprin β, a novel mediator of vascular remodelling underlying pulmonary hypertension.
    Biasin V; Marsh LM; Egemnazarov B; Wilhelm J; Ghanim B; Klepetko W; Wygrecka M; Olschewski H; Eferl R; Olschewski A; Kwapiszewska G
    J Pathol; 2014 May; 233(1):7-17. PubMed ID: 24258247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicle cross-talk between pulmonary artery smooth muscle cells and endothelium during excessive TGF-β signalling: implications for PAH vascular remodelling.
    de la Cuesta F; Passalacqua I; Rodor J; Bhushan R; Denby L; Baker AH
    Cell Commun Signal; 2019 Nov; 17(1):143. PubMed ID: 31703702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex.
    Le Hiress M; Tu L; Ricard N; Phan C; Thuillet R; Fadel E; Dorfmüller P; Montani D; de Man F; Humbert M; Huertas A; Guignabert C
    Am J Respir Crit Care Med; 2015 Oct; 192(8):983-97. PubMed ID: 26203495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of prolyl hydroxylase domain protein 2 in vascular endothelium increases pericyte coverage and promotes pulmonary arterial remodeling.
    Wang S; Zeng H; Xie XJ; Tao YK; He X; Roman RJ; Aschner JL; Chen JX
    Oncotarget; 2016 Sep; 7(37):58848-58861. PubMed ID: 27613846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of endothelial CD39/ENTPD1 is associated with pulmonary vascular remodeling in pulmonary arterial hypertension.
    Helenius MH; Vattulainen S; Orcholski M; Aho J; Komulainen A; Taimen P; Wang L; de Jesus Perez VA; Koskenvuo JW; Alastalo TP
    Am J Physiol Lung Cell Mol Physiol; 2015 May; 308(10):L1046-57. PubMed ID: 25820525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial inflammation: the role of differential expression of N-deacetylase/N-sulphotransferase enzymes in alteration of the immunological properties of heparan sulphate.
    Carter NM; Ali S; Kirby JA
    J Cell Sci; 2003 Sep; 116(Pt 17):3591-600. PubMed ID: 12876215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
    Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
    Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 expression in plexiform lesions of idiopathic pulmonary arterial hypertension.
    Ohta-Ogo K; Hao H; Ishibashi-Ueda H; Hirota S; Nakamura K; Ohe T; Ito H
    Pathol Int; 2012 Apr; 62(4):219-25. PubMed ID: 22449225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meprin inhibitor suppresses atherosclerotic plaque formation in ApoE-/- mice.
    Gao P; Guo RW; Chen JF; Chen Y; Wang H; Yu Y; Huang L
    Atherosclerosis; 2009 Nov; 207(1):84-92. PubMed ID: 19464686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial Heparan Sulfate Mediates Hepatic Neutrophil Trafficking and Injury during Staphylococcus aureus Sepsis.
    Golden GJ; Toledo AG; Marki A; Sorrentino JT; Morris C; Riley RJ; Spliid C; Chen Q; Cornax I; Lewis NE; Varki N; Le D; Malmström J; Karlsson C; Ley K; Nizet V; Esko JD
    mBio; 2021 Oct; 12(5):e0118121. PubMed ID: 34544271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased hyaluronic acid content in idiopathic pulmonary arterial hypertension.
    Papakonstantinou E; Kouri FM; Karakiulakis G; Klagas I; Eickelberg O
    Eur Respir J; 2008 Dec; 32(6):1504-12. PubMed ID: 18768572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung-specific RNA interference of coupling factor 6, a novel peptide, attenuates pulmonary arterial hypertension in rats.
    Yin J; You S; Li N; Jiao S; Hu H; Xue M; Wang Y; Cheng W; Liu J; Xu M; Yan S; Li X
    Respir Res; 2016 Aug; 17(1):99. PubMed ID: 27491388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension.
    Lepetit H; Eddahibi S; Fadel E; Frisdal E; Munaut C; Noel A; Humbert M; Adnot S; D'Ortho MP; Lafuma C
    Eur Respir J; 2005 May; 25(5):834-42. PubMed ID: 15863640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for cell fusion is absent in vascular lesions associated with pulmonary arterial hypertension.
    Majka SM; Skokan M; Wheeler L; Harral J; Gladson S; Burnham E; Loyd JE; Stenmark KR; Varella-Garcia M; West J
    Am J Physiol Lung Cell Mol Physiol; 2008 Dec; 295(6):L1028-39. PubMed ID: 18931051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis.
    Schmidt EP; Yang Y; Janssen WJ; Gandjeva A; Perez MJ; Barthel L; Zemans RL; Bowman JC; Koyanagi DE; Yunt ZX; Smith LP; Cheng SS; Overdier KH; Thompson KR; Geraci MW; Douglas IS; Pearse DB; Tuder RM
    Nat Med; 2012 Aug; 18(8):1217-23. PubMed ID: 22820644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator inhibitor type 1 inhibits smooth muscle cell proliferation in pulmonary arterial hypertension.
    Kouri FM; Queisser MA; Königshoff M; Chrobak I; Preissner KT; Seeger W; Eickelberg O
    Int J Biochem Cell Biol; 2008; 40(9):1872-82. PubMed ID: 18337154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-type voltage gated calcium channels are involved in endothelium-dependent relaxation of mice pulmonary artery.
    Gilbert G; Courtois A; Dubois M; Cussac LA; Ducret T; Lory P; Marthan R; Savineau JP; Quignard JF
    Biochem Pharmacol; 2017 Aug; 138():61-72. PubMed ID: 28438566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
    Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Extracellular Vesicles in Pulmonary Arterial Hypertension: Modulation of Pulmonary Endothelial Function and Angiogenesis.
    Khandagale A; Åberg M; Wikström G; Bergström Lind S; Shevchenko G; Björklund E; Siegbahn A; Christersson C
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2293-2309. PubMed ID: 32757648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.